VXRT
Price
$0.43
Change
-$0.02 (-4.44%)
Updated
Apr 29, 02:53 PM (EDT)
Capitalization
102.05M
21 days until earnings call
XBIO
Price
$2.89
Change
+$0.09 (+3.21%)
Updated
Apr 29, 01:58 PM (EDT)
Capitalization
4.32M
Ad is loading...

VXRT vs XBIO

Header iconVXRT vs XBIO Comparison
Open Charts VXRT vs XBIOBanner chart's image
Vaxart
Price$0.43
Change-$0.02 (-4.44%)
Volume$300
Capitalization102.05M
Xenetic Biosciences
Price$2.89
Change+$0.09 (+3.21%)
Volume$100
Capitalization4.32M
VXRT vs XBIO Comparison Chart
Loading...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VXRT vs. XBIO commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VXRT is a StrongBuy and XBIO is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (VXRT: $0.45 vs. XBIO: $2.80)
Brand notoriety: VXRT and XBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VXRT: 242% vs. XBIO: 48%
Market capitalization -- VXRT: $102.05M vs. XBIO: $4.32M
VXRT [@Biotechnology] is valued at $102.05M. XBIO’s [@Biotechnology] market capitalization is $4.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VXRT’s FA Score shows that 1 FA rating(s) are green whileXBIO’s FA Score has 1 green FA rating(s).

  • VXRT’s FA Score: 1 green, 4 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both VXRT and XBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VXRT’s TA Score shows that 4 TA indicator(s) are bullish while XBIO’s TA Score has 4 bullish TA indicator(s).

  • VXRT’s TA Score: 4 bullish, 4 bearish.
  • XBIO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VXRT is a better buy in the short-term than XBIO.

Price Growth

VXRT (@Biotechnology) experienced а +40.58% price change this week, while XBIO (@Biotechnology) price change was +14.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.16%. For the same industry, the average monthly price growth was -0.91%, and the average quarterly price growth was -9.87%.

Reported Earning Dates

VXRT is expected to report earnings on Aug 07, 2025.

XBIO is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (+5.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VXRT($102M) has a higher market cap than XBIO($4.32M). XBIO YTD gains are higher at: -29.825 vs. VXRT (-32.457). XBIO has higher annual earnings (EBITDA): -4.36M vs. VXRT (-60.22M). VXRT has more cash in the bank: 58.7M vs. XBIO (6.84M). XBIO has less debt than VXRT: XBIO (153K) vs VXRT (18.2M). VXRT has higher revenues than XBIO: VXRT (20.1M) vs XBIO (2.52M).
VXRTXBIOVXRT / XBIO
Capitalization102M4.32M2,362%
EBITDA-60.22M-4.36M1,381%
Gain YTD-32.457-29.825109%
P/E RatioN/AN/A-
Revenue20.1M2.52M797%
Total Cash58.7M6.84M858%
Total Debt18.2M153K11,895%
FUNDAMENTALS RATINGS
VXRT vs XBIO: Fundamental Ratings
VXRT
XBIO
OUTLOOK RATING
1..100
713
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
9287
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XBIO's Valuation (17) in the Biotechnology industry is in the same range as VXRT (31). This means that XBIO’s stock grew similarly to VXRT’s over the last 12 months.

XBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VXRT (100). This means that XBIO’s stock grew similarly to VXRT’s over the last 12 months.

XBIO's SMR Rating (94) in the Biotechnology industry is in the same range as VXRT (96). This means that XBIO’s stock grew similarly to VXRT’s over the last 12 months.

XBIO's Price Growth Rating (87) in the Biotechnology industry is in the same range as VXRT (92). This means that XBIO’s stock grew similarly to VXRT’s over the last 12 months.

XBIO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VXRT (100). This means that XBIO’s stock grew similarly to VXRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VXRTXBIO
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYPIX52.66N/A
N/A
Rydex Transportation Inv
TARKX24.41N/A
N/A
Tarkio
HGOFX60.01N/A
N/A
Hartford Growth Opportunities F
VESGX43.33N/A
N/A
Vanguard Global ESG Select Stk Admiral
MMFYX15.69N/A
N/A
MassMutual Equity Opports Svc

VXRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VXRT has been loosely correlated with AXON. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VXRT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VXRT
1D Price
Change %
VXRT100%
+11.60%
AXON - VXRT
50%
Loosely correlated
-0.22%
ARRY - VXRT
48%
Loosely correlated
+5.38%
AMRN - VXRT
42%
Loosely correlated
-1.05%
ALNY - VXRT
39%
Loosely correlated
+1.31%
CVAC - VXRT
37%
Loosely correlated
+7.43%
More

XBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIO has been loosely correlated with SYRE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIO jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIO
1D Price
Change %
XBIO100%
+0.27%
SYRE - XBIO
34%
Loosely correlated
+3.82%
VXRT - XBIO
29%
Poorly correlated
+11.60%
CDTX - XBIO
28%
Poorly correlated
-2.37%
VKTX - XBIO
27%
Poorly correlated
+3.80%
AUTL - XBIO
27%
Poorly correlated
+4.51%
More